Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

Anand A Dalal1, Meaghan St Charles2, Hans V Petersen2, Melissa H Roberts2, Christopher M Blanchette2, Kathy Manavi-Zieverink31US Health Outcomes, GlaxoSmithKline, Research Triangle Park, NC, 2Division of Clinical and Outcomes Research, Lovelace Respiratory Research Institute, Kannapolis USA; 3INC Re...

Full description

Bibliographic Details
Main Authors: An, A Dalal, Meaghan St Charles, Hans V Petersen, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-06-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/cost-effectiveness-of-combination-fluticasone-propionatendashsalmetero-a4571

Internet

http://www.dovepress.com/cost-effectiveness-of-combination-fluticasone-propionatendashsalmetero-a4571

Similar Items